See more : Wealth Minerals Ltd. (WMLLF) Income Statement Analysis – Financial Results
Complete financial analysis of IR Biosciences Holdings Inc. (IRBS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of IR Biosciences Holdings Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Xi’an Haitian Antenna Technologies Co., Ltd. (8227.HK) Income Statement Analysis – Financial Results
- Telecure Technologies Inc. (TELE.CN) Income Statement Analysis – Financial Results
- Samsung Electronics Co., Ltd. (SSNLF) Income Statement Analysis – Financial Results
- Universus Photo Imagings Limited (UNIVPHOTO.BO) Income Statement Analysis – Financial Results
- Haymaker Acquisition Corp. III (HYACU) Income Statement Analysis – Financial Results
IR Biosciences Holdings Inc. (IRBS)
Industry: Biotechnology
Sector: Healthcare
About IR Biosciences Holdings Inc.
IR BioSciences Holdings, Inc. operates as a development stage biotechnology company in the United States. The company, through its subsidiary, ImmuneRegen BioSciences, Inc., engages in the research and development of therapies in the areas of pulmonary fibrosis, influenza infection, and radiation-induced Neutropenia. It is involved in the development of Homspera, and its derivates Radilex and Viprovex, for human stem cell stimulation, immune system stimulation and anti-infective activity, vaccine adjuvancy, and wound healing. IR BioSciences Holdings, Inc. was founded in 1999 and is headquartered in Scottsdale, Arizona.
Source: https://incomestatements.info
Category: Stock Reports